FINN's Kristie Kuhl Takes Helm of FINN Global Health Practice
Promotion signals Health Practice transformation and will impact agency-wide growth.
FINN Partners has announced the promotion of Kristie Kuhl, JD, to managing partner, Global Health Practice Leader. The promotion recognizes Kuhl's outstanding contributions to client successes, Health Practice and agency-wide growth, and mobilizing account teams across FINN offices in the service of championing health innovation.
Kuhl joined Finn Partners in 2015 as U.S. Pharma and NY Health Head. She came to FINN after serving as an executive vice president at agencies Cohn & Wolfe and Makovsky, where she drew on her knowledge of pharma marketing, regulatory law, patient advocacy and the U.S. reimbursement system to advance breakthrough therapies. Kuhl received her law degree from Quinnipiac University after working as a leader in a cancer patient advocacy organization. Honoring her achievements at FINN, PM360 recognized her as one of the health industry's inspirational leaders in 2017 and PR News named her to their "Top Women in PR" in 2020.
Read more about Kuhl’s promotion here.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
